NIH Should Open Patents For Abbott HIV Drug, Petition Says
Four organizations on Thursday petitioned the National Institutes of Health for march-in rights for the patents to Abbott Laboratories' Norvir, a drug used to treat HIV, arguing that NIH should grant...To view the full article, register now.
Already a subscriber? Click here to view full article